Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HTY Stock Summary
Top 10 Correlated ETFs
HTY
In the News

HTY: Sub-Scale Return Of Principal Fund
The HTY fund aims to provide high current income from a portfolio of global stocks. The fund has underperformed global index funds on long-term horizons.

HTY: Some Good Qualities, But It May Be Overdistributing
HTY invests in a well-diversified portfolio of both domestic and foreign companies in order to generate current income and gains for investors. The portfolio consists entirely of dividend-paying stocks, which is quite a bit better than some of the other equity income funds in the market.

HTY: Global Equities CEF With A 9.34% Yield
The vehicle focuses on large capitalization value stocks with a global mandate.

HTY: Global Income, A High Yield, And Good Valuation
Investors have been struggling for a long time to generate any sort of income due to the policies of the Federal Reserve. HTY invests in a global portfolio of dividend-paying stocks to produce a very attractive 9.92% yield.

'Slip, Slidin Away' - What Happens To Funds That Over-Distribute Their Earnings
'Slip, Slidin Away' - What Happens To Funds That Over-Distribute Their Earnings

HTY: An Appealing CEF With A 9.65% Yield
One of the things that many investors need is income and this fund offers a great way to get that.

CEF Weekly Market Review: Another Strong Month
We review CEF market valuation and performance over the past week and highlight recent events. We discuss news and market action across a number of funds such as FCT, UTG, KYN, KMF, RTAI, and others.

Beware Of Underperforming General Equity CEFs
Equity CEFs are one of the few ways investors can receive strong distributions from equity investments, and with strong discounts to boot.

Weekly CEF Commentary Aug. 9, 2020: Some Opportunities Available
The macro picture hasn't been getting any clearer. For one, the unemployment benefits issue hasn't been resolved in Congress.
John Hancock Closed-End Funds Release Earnings Data
The eight John Hancock Closed-End Funds listed in the table below announced earnings1 for the three months ended July 31, 2020. The same data for the comparable three month period ended July 31, 2019 is also available below.
HTY Financial details
HTY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-10-31
Metric | History | 2018-10-31 | 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 |
---|---|---|---|---|---|---|
Revenue per share | -0.38 | 0.67 | -1.14 | 1.39 | -0.47 | |
Net income per share | -0.45 | 0.61 | -1.19 | 1.33 | -0.52 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 7.77 | 7.52 | 5.76 | 6.47 | 5.29 | |
Tangible book value per share | 7.77 | 7.62 | 5.79 | 6.48 | 5.29 | |
Share holders equity per share | 7.77 | 7.52 | 5.76 | 6.47 | 5.29 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 74.95M | 76.73M | 52.03M | 69.89M | 51.59M | |
Enterprise value | 74.95M | 76.73M | 52.03M | 69.89M | 51.59M | |
P/E ratio | -15.36 | 11.36 | -3.99 | 4.81 | -8.99 | |
Price to sales ratio | -18.01 | 10.37 | -4.15 | 4.6 | -9.96 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.89 | 0.92 | 0.82 | 0.99 | 0.89 | |
PTB ratio | 0.89 | 0.92 | 0.82 | 0.99 | 0.89 | |
EV to sales | -18.01 | 10.37 | -4.15 | 4.6 | -9.96 | |
Enterprise value over EBITDA | -15.36 | 11.36 | -3.99 | 4.81 | -8.99 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.07 | 0.09 | -0.25 | 0.21 | -0.11 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.16 | 0 | 18.49 | 8.57 | 236.93 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | -0.08 | 0.04 | -0.02 | 0.02 | -0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.87 | 10.16 | 12.42 | 13.92 | 7.9 | |
ROIC | -0.06 | 0.08 | -0.21 | 0.21 | -0.1 | |
Return on tangible assets | -0.05 | 0.08 | -0.21 | 0.2 | -0.1 | |
Graham Net | -0.08 | 0.06 | 0.07 | 0.04 | 0.02 | |
Working capital | 678.1K | 944.81K | 1.09M | 598.48K | 799.57K | |
Tangible asset value | 84.31M | 84.35M | 63.44M | 70.79M | 57.97M | |
Net current asset value | 329.01K | 944.81K | 1.09M | 598.48K | 431.73K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 5.74M | 2.97M | 1.05M | 913.08K | 740.23K | |
Average payables | 4.51M | 2.15M | 31.07K | 70.58K | 41.2K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | -437.37 | 46.59 | -33.43 | 16.28 | -56.61 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | -0.83 | 7.83 | -10.92 | 22.43 | -6.45 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.06 | 0.08 | -0.21 | 0.21 | -0.1 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-04-30 for Q1
Metric | History | 2022-04-30 | 2022-10-31 | 2022-10-31 | 2023-04-30 | 2023-04-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 0 | -310 | -310 | -22.73K | -22.73K | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 2.9K | 236.93 | 236.93 | 218.77 | 218.77 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 683.79K | 799.57K | 799.57K | 644.17K | 644.17K | |
Tangible asset value | 66.55M | 57.97M | 58.34M | 60.3M | 60.3M | |
Net current asset value | 577.46K | 431.73K | 799.57K | 644.17K | 644.17K | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 802.95K | 624.39K | 713.67K | |
Average payables | 0 | 0 | 3.39K | 2.96K | 3.17K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
HTY Frequently Asked Questions
What is John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund stock symbol ?
John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund is a US stock , located in Boston of Ma and trading under the symbol HTY
What is John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund stock quote today ?
John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund stock price is $4.35 today.
Is John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund stock public?
Yes, John Hancock Investments - John Hancock Tax-Advantaged Global Shareholder Yield Fund is a publicly traded company.